Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
IMAC | BACK | 27. nov 2024 | 1.04 | -0.17 |
IMAX | IMAX | 27. nov 2024 | 26.03 | +3.13 |
Immatics | IMTX | 27. nov 2024 | 7.91 | +1.41 |
Immersion | IMMR | 27. nov 2024 | 8.80 | -1.46 |
Immix Biopharma | IMMX | 27. nov 2024 | 1.97 | +19.39 |
ImmuCell | ICCC | 27. nov 2024 | 3.72 | +0.54 |
Immuneering A | IMRX | 27. nov 2024 | 2.13 | +3.90 |
Immunic | IMUX | 27. nov 2024 | 1.20 | +5.26 |
ImmunityBio | IBRX | 27. nov 2024 | 5.10 | -0.39 |
Immunocore ADR | IMCR | 27. nov 2024 | 32.83 | +1.17 |
Immunome | IMNM | 27. nov 2024 | 13.47 | +16.83 |
ImmunoPrecise Antibodies | IPA | 27. nov 2024 | 0.40 | -2.08 |
Immunovant | IMVT | 27. nov 2024 | 28.73 | +5.78 |
Immutep ADR | IMMP | 27. nov 2024 | 1.99 | +4.19 |
Imperial Oil | IMO | 27. nov 2024 | 73.14 | -0.68 |
Imperial Petroleum | IMPP | 27. nov 2024 | 3.20 | -0.78 |
Imperial Petroleum A Pref | IMPPP | 27. nov 2024 | 25.60 | +1.11 |
Impinj | PI | 27. nov 2024 | 189.25 | -3.23 |
Imunon | IMNN | 27. nov 2024 | 0.86 | +3.27 |
IN8bio | INAB | 27. nov 2024 | 0.30 | -4.45 |
Inari Medical | NARI | 27. nov 2024 | 51.03 | +0.39 |
Incannex Healthcare ADR | IXHL | 27. nov 2024 | 1.82 | -1.62 |
Inception Growth Acquisition | IGTA | 27. nov 2024 | 11.72 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | 27. nov 2024 | 11.75 | +1.29 |
Income Opportunity Realty Investors | IOR | 27. nov 2024 | 16.01 | 0.00 |
Incyte | INCY | 27. nov 2024 | 75.45 | +0.87 |
Indaptus Therapeutics | INDP | 27. nov 2024 | 1.03 | -0.96 |
Independence Realty Trust | IRT | 27. nov 2024 | 22.01 | +1.29 |
Independent Bank | IBCP | 27. nov 2024 | 37.94 | -0.89 |
Independent Bank | INDB | 27. nov 2024 | 72.99 | -0.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.